{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:27:28Z","timestamp":1793946448156,"version":"4.8.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011710","name":"Shaanxi Province Department of Science and Technology","doi-asserted-by":"publisher","award":["2025JC-YBQN-050"],"award-info":[{"award-number":["2025JC-YBQN-050"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Province Department of Science and Technology","doi-asserted-by":"publisher","award":["2025\\u202FZC-KJXX-07"],"award-info":[{"award-number":["2025\\u202FZC-KJXX-07"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Province Department of Science and Technology","doi-asserted-by":"publisher","award":["2023-JC-QN-0999"],"award-info":[{"award-number":["2023-JC-QN-0999"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017614","name":"Xi'an Medical University","doi-asserted-by":"publisher","award":["2023BS12"],"award-info":[{"award-number":["2023BS12"]}],"id":[{"id":"10.13039\/501100017614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017614","name":"Xi'an Medical University","doi-asserted-by":"publisher","award":["205042304"],"award-info":[{"award-number":["205042304"]}],"id":[{"id":"10.13039\/501100017614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017614","name":"Xi'an Medical University","doi-asserted-by":"publisher","award":["2024QN14"],"award-info":[{"award-number":["2024QN14"]}],"id":[{"id":"10.13039\/501100017614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017614","name":"Xi'an Medical University","doi-asserted-by":"publisher","award":["202511840017"],"award-info":[{"award-number":["202511840017"]}],"id":[{"id":"10.13039\/501100017614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017614","name":"Xi'an Medical University","doi-asserted-by":"publisher","award":["2025RCYJ01"],"award-info":[{"award-number":["2025RCYJ01"]}],"id":[{"id":"10.13039\/501100017614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017614","name":"Xi'an Medical University","doi-asserted-by":"publisher","award":["2024BS09"],"award-info":[{"award-number":["2024BS09"]}],"id":[{"id":"10.13039\/501100017614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Province","doi-asserted-by":"publisher","award":["24JK0650"],"award-info":[{"award-number":["24JK0650"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Province","doi-asserted-by":"publisher","award":["23JS055"],"award-info":[{"award-number":["23JS055"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Province","doi-asserted-by":"publisher","award":["20250713"],"award-info":[{"award-number":["20250713"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504744"],"award-info":[{"award-number":["82504744"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200513"],"award-info":[{"award-number":["82200513"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.yexcr.2026.115040","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:57:47Z","timestamp":1776985067000},"page":"115040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of disease-modifying anti-rheumatic drugs (DMARDs) in cardiovascular risk management induced by rheumatoid arthritis"],"prefix":"10.1016","volume":"459","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6857-3219","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Xia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0022-4173","authenticated-orcid":false,"given":"Jia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Quan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4550-3505","authenticated-orcid":false,"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Qing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ling","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2026.115040_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.yexcr.2026.115040_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: extra-Articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.yexcr.2026.115040_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/BOR.0000000000001004","article-title":"Cardiovascular complications of rheumatoid arthritis","volume":"36","author":"Park","year":"2024","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.yexcr.2026.115040_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbspin.2012.02.005","article-title":"Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis","volume":"80","author":"Dadoun","year":"2013","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.yexcr.2026.115040_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/20503121251330171","article-title":"Interplay of rheumatoid arthritis and cardiovascular disease: insights and prospects","volume":"13","author":"Poznyak","year":"2025","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.yexcr.2026.115040_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/jcm12010208","article-title":"Hormonal and reproductive factors in relation to cardiovascular events in women with early rheumatoid arthritis","volume":"12","author":"Boman","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.yexcr.2026.115040_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcmg.2014.12.025","article-title":"Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping","volume":"8","author":"Ntusi","year":"2015","journal-title":"JACC, Cardiovasc. Imaging"},{"key":"10.1016\/j.yexcr.2026.115040_bib8","article-title":"Cardiovascular risk in patients with rheumatoid arthritis","volume":"39","author":"K","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.yexcr.2026.115040_bib9","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/eurheartj\/ehv461","article-title":"Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome","volume":"36","author":"Mantel","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yexcr.2026.115040_bib10","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00296-020-04691-5","article-title":"Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging","volume":"40","author":"Jamthikar","year":"2020","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.yexcr.2026.115040_bib11","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s10067-024-06996-3","article-title":"Cardiovascular disease risk assessment in patients with rheumatoid arthritis: a scoping review","volume":"43","author":"Murphy","year":"2024","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.yexcr.2026.115040_bib12","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/art.21932","article-title":"Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis","volume":"54","author":"Van Doornum","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexcr.2026.115040_bib13","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/annrheumdis-2013-203617","article-title":"Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease","volume":"73","author":"Karpouzas","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yexcr.2026.115040_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220510","article-title":"Comparative study of pressure (ankle-brachial pressure index) and flow (strain gauge plethysmography and reactive hyperaemia) measurements in diagnosis of peripheral arterial disease in patients with severe aortic stenosis","volume":"14","author":"Schahab","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2026.115040_bib15","first-page":"399","article-title":"Peripheral vascular disease","volume":"4","author":"Lawrence","year":"2011","journal-title":"InnovAiT Educ. Inspir. Gen. Pract."},{"key":"10.1016\/j.yexcr.2026.115040_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1160\/th15-07-0600","article-title":"Risk of peripheral arterial occlusive disease in patients with rheumatoid arthritis. A nationwide population-based cohort study","volume":"115","author":"Chuang","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.yexcr.2026.115040_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13075-014-0435-y","article-title":"A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases","volume":"16","author":"Lee","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.yexcr.2026.115040_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.33322","article-title":"Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events?","volume":"64","author":"Bacani","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexcr.2026.115040_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11886-020-01415-w","article-title":"Pericarditis in systemic rheumatologic diseases","volume":"22","author":"Kontzias","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.yexcr.2026.115040_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-9343(79)91056-8","article-title":"Pericardial disease in rheumatoid arthritis","volume":"66","author":"John","year":"1979","journal-title":"Am. J. Med."},{"key":"10.1016\/j.yexcr.2026.115040_bib21","first-page":"85","article-title":"Canadian cardiovascular society, Canadian cardiovascular society consensus conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials","volume":"25","author":"Howlett","year":"2009","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.yexcr.2026.115040_bib22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/rheumatology\/keu368","article-title":"Disease activity and left ventricular structure in patients with rheumatoid arthritis","volume":"54","author":"Midtb\u00f8","year":"2015","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.yexcr.2026.115040_bib23","article-title":"Aortic regurgitation and rheumatoid arthritis","volume":"29","author":"Selinski","year":"2024","journal-title":"JACC Case Rep."},{"key":"10.1016\/j.yexcr.2026.115040_bib24","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.ijcard.2012.05.057","article-title":"Heart involvement in rheumatoid arthritis: systematic review and meta-analysis","volume":"167","author":"Corrao","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yexcr.2026.115040_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.862164","article-title":"Role of inflammation in the pathogenesis of atrial fibrillation","volume":"13","author":"Ihara","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yexcr.2026.115040_bib26","first-page":"1717","article-title":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","volume":"38","author":"Lazzerini","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yexcr.2026.115040_bib27","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/acr.24804","article-title":"The association between inflammation, incident heart failure, and heart failure subtypes in patients with rheumatoid arthritis","volume":"75","author":"Huang","year":"2023","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.yexcr.2026.115040_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.41979","article-title":"Myocardial dysfunction and heart failure in rheumatoid arthritis","volume":"74","author":"Park","year":"2022","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"10.1016\/j.yexcr.2026.115040_bib29","first-page":"319","article-title":"Cardiovascular risk assessment in rheumatoid arthritis: accelerated atherosclerosis, new biomarkers, and the effects of biological therapy","volume":"13","author":"Popescu","year":"2023","journal-title":"Life Basel Switz"},{"key":"10.1016\/j.yexcr.2026.115040_bib30","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Ma","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2026.115040_bib31","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41598-018-20220-8","article-title":"The inflammatory effects of TNF-\u03b1 and complement component 3 on coagulation","volume":"8","author":"Page","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2026.115040_bib32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cvr\/cvab005","article-title":"TNF\u03b1 induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNF\u03b1 antibodies","volume":"118","author":"Akhmedov","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2026.115040_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115040_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155742","article-title":"Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints","volume":"149","author":"Jarlborg","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.yexcr.2026.115040_bib35","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00018-015-2080-2","article-title":"Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential","volume":"73","author":"Spitz","year":"2016","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.yexcr.2026.115040_bib36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.121.053547","article-title":"Interleukin-1\u03b1 is a central regulator of leukocyte-endothelial adhesion in myocardial infarction and in chronic kidney disease","volume":"144","author":"Schunk","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2026.115040_bib37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12964-025-02331-8","article-title":"ACPA-induced ATP release and K+ efflux trigger NLRP3 inflammasome activation in rheumatoid arthritis","volume":"23","author":"Cai","year":"2025","journal-title":"Cell Commun. Signal. CCS"},{"key":"10.1016\/j.yexcr.2026.115040_bib38","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115040_bib39","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"Br. Med. J."},{"key":"10.1016\/j.yexcr.2026.115040_bib40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","article-title":"Metabolic regulation of the immune system in health and diseases: mechanisms and interventions","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.yexcr.2026.115040_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413337","article-title":"Immune and metabolic mechanisms of endothelial dysfunction","volume":"25","author":"Kopaliani","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115040_bib42","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-025-07587-6","article-title":"Relationship between serum vitamin D levels and pro-inflammatory cytokines in patients with rheumatoid arthritis combined with cardiovascular disease","author":"Zha","year":"2025","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.yexcr.2026.115040_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101002","article-title":"Cardiovascular disease risk factors in newly diagnosed rheumatoid arthritis: a retrospective cohort study","volume":"22","author":"Aronov","year":"2025","journal-title":"Am. J. Prev. Cardiol."},{"issue":"25","key":"10.1016\/j.yexcr.2026.115040_bib44","article-title":"Lipoprotein(a) at the crossroads of inflammation and atherosclerosis in rheumatoid arthritis: a narrative review","volume":"S1933\u20132874","author":"Yuliasih","year":"2025","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.yexcr.2026.115040_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119244","article-title":"Association of Lipoprotein(a) with cardiovascular events among individuals with autoimmune conditions","volume":"406","author":"Alebna","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yexcr.2026.115040_bib46","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3390\/nu11092090","article-title":"Oxidative stress in cardiovascular diseases: still a therapeutic target?","volume":"11","author":"Senoner","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.yexcr.2026.115040_bib47","article-title":"ProBNP, cytokines, and the Nrf2\/HO-1 signaling pathway: a cross-sectional study on cardiovascular risk in rheumatoid arthritis","volume":"278","author":"Nobre","year":"2025","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"10.1016\/j.yexcr.2026.115040_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2025.111265","article-title":"Associations of HLA-DRB1 shared epitope alleles with cardiovascular disease and events in a multi-ethnic community-living population: the multi-ethnic study of atherosclerosis (MESA)","volume":"86","author":"Kaur","year":"2025","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.yexcr.2026.115040_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186625","article-title":"Protein tyrosine phosphatase PTPN22 is dispensable for dendritic cell antigen processing and promotion of T-cell activation by dendritic cells","volume":"12","author":"Clarke","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2026.115040_bib50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00281-017-0621-5","article-title":"Epigenetics in the pathogenesis of RA","volume":"39","author":"Ospelt","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.yexcr.2026.115040_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152031","article-title":"Methotrexate use reduces mortality risk in rheumatoid arthritis: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Xu","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.yexcr.2026.115040_bib52","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.5001\/omj.2021.25","article-title":"Cardiovascular risk in rheumatoid arthritis: literature review","volume":"36","author":"Ma Hannawi","year":"2021","journal-title":"Oman Med. J."},{"key":"10.1016\/j.yexcr.2026.115040_bib53","first-page":"78","article-title":"Anti-inflammatory drug candidates for prevention and treatment of cardiovascular diseases","volume":"16","author":"Delbaere","year":"2023","journal-title":"Pharm. Basel Switz."},{"key":"10.1016\/j.yexcr.2026.115040_bib54","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","article-title":"The role of TNF-Alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk","volume":"48","author":"Popa","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.yexcr.2026.115040_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.41095","article-title":"Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial","volume":"72","author":"Giles","year":"2020","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"10.1016\/j.yexcr.2026.115040_bib56","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s40264-025-01535-8","article-title":"Major adverse cardiovascular events related to JAK inhibitors: a disproportionality analysis using the WHO global individual case safety database","volume":"48","author":"Di Napoli","year":"2025","journal-title":"Drug Saf."},{"key":"10.1016\/j.yexcr.2026.115040_bib57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semarthrit.2025.152721","article-title":"Risk of major adverse cardiovascular events following targeted therapy in patients with rheumatoid arthritis: a real-world analysis stratified by cardiovascular risk","volume":"73","author":"You","year":"2025","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.yexcr.2026.115040_bib58","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2026.115040_bib59","first-page":"14","article-title":"Clinical value of myocardial enzyme testing in patients with rheumatoid arthritis","volume":"31","author":"Wang","year":"2014","journal-title":"Med. Res. Educ."},{"key":"10.1016\/j.yexcr.2026.115040_bib60","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3899\/jrheum.2024-0723","article-title":"High-sensitivity cardiac troponin T as a marker to improve cardiovascular disease risk assessment among patients with rheumatoid arthritis","volume":"52","author":"Wang","year":"2025","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.yexcr.2026.115040_bib61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12953-025-00243-6","article-title":"Plasma proteome analysis of rheumatic patients reveals differences in fingerprints based on cardiovascular history: a pilot study","volume":"23","author":"Hansildaar","year":"2025","journal-title":"Proteome Sci."},{"key":"10.1016\/j.yexcr.2026.115040_bib62","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s10753-024-02157-5","article-title":"Exploration of risk factors for cardiovascular disease in patients with rheumatoid arthritis: a retrospective study","volume":"48","author":"Feng","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.yexcr.2026.115040_bib63","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s10067-025-07364-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis","volume":"44","author":"Saidi","year":"2025","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.yexcr.2026.115040_bib64","article-title":"Levels of sCD163 in women rheumatoid arthritis: relationship with cardiovascular risk markers","volume":"37","author":"Zaragoza-Garc\u00eda","year":"2025","journal-title":"Clin. E Investig. En Arterioscler. Publicacion Of. Soc. Espanola Arterioscler."},{"key":"10.1016\/j.yexcr.2026.115040_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.33393\/jcb.2025.3175","article-title":"Soluble interleukin-33 receptor (sST-2): a novel marker for assessing cardiovascular risk in rheumatoid arthritis","volume":"14","author":"Claus","year":"2025","journal-title":"J. Circ. Biomark."},{"key":"10.1016\/j.yexcr.2026.115040_bib66","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1007\/s12011-024-04434-8","article-title":"Serum levels of trace elements (magnesium, iron, zinc, selenium, and strontium) are differentially associated with surrogate markers of cardiovascular disease risk in patients with rheumatoid arthritis","volume":"203","author":"Vera","year":"2025","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.yexcr.2026.115040_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00296-025-05936-x","article-title":"Cardiovascular vasculopathy in gout and rheumatoid arthritis: a shared perspective","volume":"45","author":"Calvo-Aranda","year":"2025","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.yexcr.2026.115040_bib68","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.yexcr.2026.115040_bib69","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yexcr.2026.115040_bib70","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.yexcr.2026.115040_bib71","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yexcr.2026.115040_bib72","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002867","article-title":"Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients","volume":"5","author":"Sharma","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yexcr.2026.115040_bib73","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/art.41803","article-title":"Cardiovascular safety of hydroxychloroquine in US veterans with rheumatoid arthritis","volume":"73","author":"Faselis","year":"2021","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"10.1016\/j.yexcr.2026.115040_bib74","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/ard-2022-223302","article-title":"TARGET trial consortium, reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis","volume":"82","author":"Solomon","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yexcr.2026.115040_bib75","article-title":"Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis","volume":"76","author":"As","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yexcr.2026.115040_bib76","article-title":"Structural insights into IL-6 signaling inhibition by therapeutic antibodies","volume":"43","author":"Wang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.yexcr.2026.115040_bib77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/acr.23875","article-title":"Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"72","author":"Singh","year":"2020","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.yexcr.2026.115040_bib78","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yexcr.2026.115040_bib79","doi-asserted-by":"crossref","DOI":"10.1134\/S1607672925700097","article-title":"Dynamics of modified cardiovascular risk factors in patients with rheumatoid arthritis on the background of 5-Year therapy with an interleukin 6 receptor inhibitor","author":"Gerasimova","year":"2025","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.yexcr.2026.115040_bib80","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2026.115040_bib81","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001267","article-title":"Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis","volume":"3","author":"Hsue","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yexcr.2026.115040_bib82","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3346\/jkms.2016.31.2.202","article-title":"The effects of rituximab on lipids, arterial stiffness and carotid intima-media thickness in rheumatoid arthritis","volume":"31","author":"Novikova","year":"2016","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.yexcr.2026.115040_bib83","article-title":"Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study","volume":"94","author":"F","year":"2015","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.yexcr.2026.115040_bib84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41584-022-00767-7","article-title":"Oral surveillance and JAK inhibitor safety: the theory of relativity","volume":"18","author":"Winthrop","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.yexcr.2026.115040_bib85","first-page":"10","article-title":"Risk of major adverse cardiovascular events and venous thromboembolism with JAK inhibitors versus TNF inhibitors in rheumatoid arthritis patients: a systematic review and meta-analysis, mediterr","volume":"35","author":"Partalidou","year":"2024","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.yexcr.2026.115040_bib86","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1093\/rheumatology\/keaf168","article-title":"CARMA project collaborative group, performance of four cardiovascular risk scales in chronic inflammatory rheumatic disease patients: 10-year follow-up data","volume":"64","author":"Llorca","year":"2025","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.yexcr.2026.115040_bib87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yexcr.2026.115040_bib88","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yexcr.2026.115040_bib89","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2026.115040_bib90","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.2147\/JIR.S276986","article-title":"Monitoring and managing cardiovascular risk in immune mediated inflammatory diseases","volume":"14","author":"Anyfanti","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.yexcr.2026.115040_bib91","article-title":"Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: results from a cross-sectional study","volume":"96","author":"Ruscitti","year":"2017","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.yexcr.2026.115040_bib92","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3899\/jrheum.160110","article-title":"Cardiovascular outcomes associated with lowering low-density lipoprotein cholesterol in rheumatoid arthritis and matched nonrheumatoid arthritis","volume":"43","author":"An","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.yexcr.2026.115040_bib93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fmed.2018.00024","article-title":"The role of statins in disease modification and cardiovascular risk in rheumatoid arthritis","volume":"5","author":"Soulaidopoulos","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.yexcr.2026.115040_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2017.11.009","article-title":"Effect of statin therapy on the prevention of new-onset acute coronary syndrome in patients with rheumatoid arthritis","volume":"253","author":"Huang","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yexcr.2026.115040_bib95","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/acr.22932","article-title":"Impact of obesity on remission and disease activity in rheumatoid arthritis: a systematic review and meta-analysis","volume":"69","author":"Liu","year":"2017","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.yexcr.2026.115040_bib96","doi-asserted-by":"crossref","first-page":"402","DOI":"10.31138\/mjr.310824.cri","article-title":"Cardiovascular risk in rheumatoid arthritis: considerations on assessment and management","volume":"35","author":"Anyfanti","year":"2024","journal-title":"Mediterr. J. Rheumatol."},{"key":"10.1016\/j.yexcr.2026.115040_bib97","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"166","author":"Crowson","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.yexcr.2026.115040_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117952","article-title":"The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"10","author":"Baghdadi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2026.115040_bib99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yexcr.2026.115040_bib106","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N","article-title":"High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy","volume":"44","author":"Verburg","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexcr.2026.115040_bib107","first-page":"482","article-title":"Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR","volume":"31","author":"Snowden","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.yexcr.2026.115040_bib108","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-981-10-4397-0_15","article-title":"Therapeutic potential of hematopoietic stem cell-derived exosomes in cardiovascular disease","volume":"998","author":"Radosinska","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.yexcr.2026.115040_bib101","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/00365513.2020.1741023","article-title":"Bone marrow- and adipose tissue-derived mesenchymal stem cells from donors with coronary artery disease; growth, yield, gene expression and the effect of oxygen concentration","volume":"80","author":"Adolfsson","year":"2020","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.yexcr.2026.115040_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105564","article-title":"Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P\/SK1\/S1PR1 signaling and promoting macrophage M2 polarization","volume":"114","author":"Deng","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yexcr.2026.115040_bib104","article-title":"Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2026.115040_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2022.102886","article-title":"Generation of two hiPSC lines, (DMBi003-A and DMBi004-A), by reprogramming peripheral blood mononuclear cells and fibroblast-like synoviocytes from rheumatoid arthritis patients","volume":"64","author":"Wolnik","year":"2022","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.yexcr.2026.115040_bib112","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/ar4470","article-title":"Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis","volume":"16","author":"Lee","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.yexcr.2026.115040_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914408","article-title":"Clinical potential of cellular material sources in the generation of iPSC-Based products for the regeneration of articular cartilage","volume":"24","author":"Eremeev","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115040_bib100","article-title":"Recent developments in clinical applications of mesenchymal stem cells in the treatment of rheumatoid arthritis and osteoarthritis","volume":"12","author":"Jj","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115040_bib102","first-page":"701","article-title":"Clinical study of human umbilical cord mesenchymal stem cell transplantation for rheumatoid arthritis","volume":"39","author":"Yang","year":"2017","journal-title":"Chin. J. Cell Biol."},{"key":"10.1016\/j.yexcr.2026.115040_bib105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2012.10.004","article-title":"Stem cells in autoimmune diseases: implications for pathogenesis and future trends in therapy","volume":"12","author":"Cipriani","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.yexcr.2026.115040_bib109","first-page":"57","article-title":"Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia","volume":"3","author":"Lu","year":"2010","journal-title":"Stem Cell. Clon Adv. Appl."},{"key":"10.1016\/j.yexcr.2026.115040_bib110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent stem cell-based cell therapy-promise and challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2026.115040_bib114","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2025.13698","article-title":"Application potential of induced pluripotent stem cells in the research and treatment of autoimmune diseases (Review)","volume":"32","author":"Ye","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yexcr.2026.115040_bib115","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5966\/sctm.2015-0101","article-title":"Cardiovascular cell therapy research network, concise review: Review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease","volume":"5","author":"Golpanian","year":"2016","journal-title":"Stem Cells Transl. Med."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:41:44Z","timestamp":1793943704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0014482726001576"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115040","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of disease-modifying anti-rheumatic drugs (DMARDs) in cardiovascular risk management induced by rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115040"}}